Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daniel Brungs"'
Autor:
Lucy Haggstrom, Robert Winn, Soni Putnis, James Chen, Morteza Aghmesheh, Elias H. Nasser, Sharlyn Kang, Daniel Brungs
Publikováno v:
ANZ Journal of Surgery. 90:2490-2495
Background As treatments for rectal cancer improve with developments in surgical techniques, radiotherapy and chemotherapy, the nature of recurrences are evolving. We used a comprehensive database of a large Australian population with stage I-III rec
Publikováno v:
Clinical Medicine Insights. Oncology
Clinical Medicine Insights: Oncology, Vol 14 (2020)
Clinical Medicine Insights: Oncology, Vol 14 (2020)
Objectives: Central venous access is needed to facilitate chemotherapy for many cancer patients. Central venous catheter-related thrombosis (CVCT) is a major complication that can cause significant morbidity and mortality. We sought to explore the ra
Autor:
June Rose, Daniel Brungs, Phillip R Clingan, Martin G Carolan, Marie Ranson, Morteza Aghmesheh, Paul de Souza
Publikováno v:
Clinical colorectal cancer. 17(3)
Colon cancer is common in the elderly, but owing to under representation in clinical trials, the benefit of standard therapies is uncertain in this age group. We aimed to clarify the efficacy and complications of adjuvant oxaliplatin and fluoropyrimi
Autor:
June Rose, Wei Chua, Martin G Carolan, Tameika Tubaro, Emma Healey, Morteza Aghmesheh, Weng Ng, Phillip R Clingan, Marie Ranson, Daniel Brungs, Paul de Souza
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)
BMC Cancer
BMC Cancer
Background/Aim Right sided colon cancer (RsCC) is proposed to be a distinct disease entity to left sided colon cancer (LsCC). We seek to confirm primary tumour location as an independent prognostic factor in locoregional colorectal cancer. Methods Al
Autor:
Wei Chua, Ray Asghari, Sarah Maloney, Cheok Soon Lee, Elias H. Nasser, Sharlyn Kang, Hiren Mandaliya, James Chen, Kate Wilkinson, Stephanie H Lim, Weng Leong Ng, Daniel Brungs
Publikováno v:
Journal of Clinical Oncology. 37:675-675
675 Background: Consensus international guidelines recommend the use of neoadjuvant chemo-radiotherapy in patients with stage II-III rectal cancer. Despite this, due to factors including inaccurate/under-staging, patient co-morbidities and acute pres